問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Tri-Service General Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
下載
2022-12-05 - 2024-09-30
Condition/Disease
Prevention of Ischemic Stroke 、Acute Non-cardioembolic Ischemic Stroke、 High-risk Transient Ischemic Attack
Test Drug
AsundexianPlacebo (for Asundexian)ApixabanPlacebo (for Apixaban)
Participate Sites23Sites
Not yet recruiting2Sites
Recruiting20Sites
Terminated1Sites
2008-01-01 - 2010-12-31
Participate Sites5Sites
Terminated5Sites
2008-03-06 - 2014-09-05
Participate Sites9Sites
Terminated9Sites
2006-11-20 - 2015-12-31
Participate Sites11Sites
Terminated11Sites
2010-04-01 - 2012-10-31
Participate Sites2Sites
Terminated2Sites
2011-03-01 - 2015-12-31
2006-02-01 - 2007-04-30
Participate Sites7Sites
Terminated7Sites
2006-09-01 - 2007-11-01
Participate Sites6Sites
Terminated6Sites
2009-07-01 - 2013-08-31
Participate Sites12Sites
Terminated12Sites
2015-06-30 - 2017-12-31
neutropenic
amphotericin B
Participate Sites10Sites
Division of Infectious Disease
全部
